Our founding team combines deep expertise in frontier biology and physical AI.

Daniel Yamamoto, PhD

CEO & Co-Founder

Cambridge-trained stem-cell biologist, published in journals including Nature. Discovered leukaemia cancer-drug candidates at AstraZeneca at age 20, developed some of the earliest approaches for generating synthetic human embryos, and uncovered how stem cells drive the development, regeneration and aging of the brain. Previously founded an AI × bio deeptech startup that raised millions in funding.

Kyo Mangold

CTO & Co-Founder

Engineer from Zurich trained in robotics and AI at ETH Zurich. His work has impacted 40% of global pasta production, millions of insurance customers worldwide, and billions of US mail pieces a year. He has experience across industry leaders like Apple, Siemens, Allianz, and J&J. After launching his privacy-first on-device LLM app, OpenAI invited him to a small-group session with Sam Altman on what became GPT-OSS.